Opportunity Information: Apply for PAR 18 585
The National Institutes of Health (NIH) funding opportunity PAR-18-585 supports pragmatic clinical trials focused on improving dementia care for people with Alzheimers disease (AD) and Alzheimers disease and related dementias (ADRD) who receive services in Long-term Services and Support (LTSS) settings. The central idea is to fund studies that answer practical, real-world questions that matter to patients living with dementia, clinicians, and caregivers, including both paid staff and unpaid family caregivers. Unlike tightly controlled efficacy studies, these projects are expected to be run in everyday care environments and structured so their findings can be used quickly by providers, organizations, patients, and caregivers.
A key expectation is that proposed trials are comparative and pragmatic, meaning they should test interventions, care strategies, or implementation approaches under routine conditions and with broad eligibility criteria. Applications are expected to enroll diverse populations and reflect the realities of LTSS, where staffing patterns, care workflows, and patient needs can vary widely. The goal is to generate evidence that is directly adoptable, not just academically interesting, and to do so in a way that supports rapid translation into practice.
The FOA emphasizes outcomes that improve the lives of people with dementia and those who care for them. Successful projects should be positioned to (1) improve the quality of care delivered to persons with dementia, (2) improve quality of life for persons with dementia and their informal caregivers, (3) deliver more patient-centered and cost-effective care within LTSS, and/or (4) reduce disparities in LTSS dementia care. In practical terms, that can include interventions that improve care processes, communication, symptom management, caregiver support, staff training, care coordination, or other approaches that can realistically be integrated into LTSS operations.
This opportunity uses a phased award structure (R61/R33) that supports a stepwise path from feasibility work to a larger pragmatic trial. The first phase functions as a pilot and feasibility stage intended to test whether an LTSS intervention can be implemented, integrated, and sustained in the targeted real-world settings. During this initial phase, applicants are expected to establish that recruitment, delivery, fidelity, data collection, and operational fit are workable, and to refine procedures needed for a larger trial. Progression to the second phase is not automatic; it depends on meeting predefined Go/No-Go milestones and criteria set for the early phase. If those criteria are achieved, the project can transition to the R33 phase to conduct the full-scale pragmatic trial.
The funding mechanism is a grant, and the activity category is health (CFDA 93.866). While the source data lists an award ceiling of $500,000, the FOA structure indicates support for pilot feasibility work followed by a larger pragmatic trial phase, with the transition governed by administrative review of milestone completion. The opportunity is labeled a clinical trial required announcement, signaling that funded projects must include a clinical trial component consistent with NIH definitions and expectations for trial conduct, oversight, and reporting.
Eligibility is broad and includes many types of organizations that operate, study, or influence LTSS and dementia care. Eligible applicants include state, county, city, township, and special district governments; public and private institutions of higher education; independent school districts; federally recognized tribal governments and other tribal organizations; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (including small businesses); and other entities. The FOA also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. (foreign) organizations. This breadth aligns with the FOA emphasis on diverse populations, community relevance, and real-world implementation capacity.
Overall, PAR-18-585 is geared toward producing actionable evidence on dementia care in LTSS by funding pragmatic, inclusive, real-world trials that can be adopted quickly, with an initial feasibility stage and a milestone-driven path to a larger implementation and effectiveness trial.Apply for PAR 18 585
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-01-24.
- Applicants must submit their applications by 2020-02-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
Previous opportunity: FY 2018 Mandela Washington Fellowship for Young African Leaders
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 585
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 585) also looked into and applied for these:
| Funding Opportunity |
|---|
| Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 018 Funding Number: RFA RM 18 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed) Apply for RFA AG 19 001 Funding Number: RFA AG 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 017 Funding Number: RFA RM 18 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) Apply for RFA RM 18 001 Funding Number: RFA RM 18 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 18 595 Funding Number: PAR 18 595 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional) Apply for PAR 18 587 Funding Number: PAR 18 587 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional) Apply for PAR 18 588 Funding Number: PAR 18 588 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 594 Funding Number: PAR 18 594 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 18 597 Funding Number: PAR 18 597 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 596 Funding Number: PAR 18 596 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed) Apply for RFA HL 19 001 Funding Number: RFA HL 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $320,000 |
| Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 19 002 Funding Number: RFA HL 19 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 608 Funding Number: PAR 18 608 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 607 Funding Number: PA 18 607 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 610 Funding Number: PA 18 610 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) Apply for PA 18 613 Funding Number: PA 18 613 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R44) - Clinical Trial Required Apply for PAR 18 618 Funding Number: PAR 18 618 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R42) - Clinical Trial Required Apply for PAR 18 617 Funding Number: PAR 18 617 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) Apply for PA 18 614 Funding Number: PA 18 614 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed) Apply for PA 18 609 Funding Number: PA 18 609 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 585", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
